Presentation TCT 2013 An Overview of Patient Risk Stratification in Patients Enrolled in the CoreValve US Extreme Risk Study Presenter: Thomas Gleason October 29, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TCT 2013 Up Next Presentation TCT 2013 TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial Presenter: Petr Neuzil October 29, 2013 More slides + Presentation TCT 2013 TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial Presenter: Ricardo Costa October 29, 2013 Presentation TCT 2013 Update on the Global Registry of Degenerative Bioprosthetic Valves Presenter: Danny Dvir October 29, 2013 We Recommend
Presentation TCT 2013 TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial Presenter: Petr Neuzil October 29, 2013
Presentation TCT 2013 TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial Presenter: Ricardo Costa October 29, 2013
Presentation TCT 2013 Update on the Global Registry of Degenerative Bioprosthetic Valves Presenter: Danny Dvir October 29, 2013